血脑屏障的药理学调节:机制,治疗策略和新兴技术
Iosif Pediaditakis1, Serena Tsakali2, Maddie R Lemieux1
1Phragma Therapeutics, Inc, Watertown, Massachusetts; Thera Phragma PC, Patras, Greece.
Pharmacological reviews
|February 10, 2026
概括
血脑屏障 (BBB) 保护大脑,但阻药物. 本综述探讨了药理学策略,以增强药物输送和恢复BBB功能,用于治疗神经系统疾病.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 生物技术是生物技术.
背景情况:
- 血脑屏障 (BBB) 对于中枢神经系统的平衡至关重要,但限制了治疗的准入.
- BBB功能障碍与各种神经系统疾病有关,包括神经退行性疾病和中风.
研究的目的:
- 提供对调节BBB功能的药理学策略的全面概述.
- 将BBB调节的机制性见解与药物输送和屏障恢复的新兴治疗方法联系起来.
主要方法:
- 对针对BBB的药理干预措施的当前文献的综述.
- 对紧密结的动力学,传送器网络和细胞相互作用的机制性见解的分析.
- 讨论治疗策略,包括小分子,生物制剂,纳米载体,基因疗法和干细胞.
主要成果:
- 药理学调制提供了暂时增强药物输送或恢复BBB完整性的潜力.
- 像BBB-on-chip和iPSC衍生模型这样的新兴技术正在加速翻译.
- 挑战包括确保安全,管理患者异质性和改进实验模型.
结论:
- BBB的药理调制代表了中枢神经系统治疗的转变性方法.
- 提高药物输送或加强屏障功能的策略可以克服重大治疗挑战.
- 在建模和分子标方面的进步正在为改进的针对大脑的治疗铺平道路.
相关概念视频
The Blood-brain Barrier
53.3K
Overview
53.3K
Emerging Adulthood
725
Jeffrey Arnett's concept of emerging adulthood offers a framework to understand the unique developmental stage between adolescence and full-fledged adulthood, generally from ages 18 to 25. This period is marked by extensive exploration and shifts in identity, relationships, and career choices, a process known in psychology as role experimentation. Emerging adulthood reflects the evolving cultural expectations surrounding adulthood and the dynamic process of personal transformation during...
725
Introduction Cardiac Emergencies
379
Cardiac emergencies are critical situations involving the heart that require immediate medical intervention to prevent severe complications or death. These emergencies often arise from underlying heart conditions that impair the heart's ability to function correctly.Types of Cardiac EmergenciesThe most common types of cardiac emergencies include Acute Coronary Syndrome (ACS), myocardial infarction (MI), cardiac arrest, and heart failure.Acute Coronary Syndrome (ACS)Acute Coronary Syndrome (ACS)...
379
Therapeutic Index
6.9K
The therapeutic index of a drug is a key parameter in pharmacology that quantifies the relative safety of a drug by calculating the ratio between the dose that causes toxicity in half the population (50%) to the dose that proves to be effective for half the population (50%). It provides a spectrum of doses for a particular drug ranging from effective to potentially toxic. To illustrate, consider an anticoagulant agent like warfarin. It possesses a narrow window within its therapeutic index to...
6.9K
Physiological Barriers
5.3K
Physiological barriers are semi-permeable cellular structures restricting drug diffusion into intracellular compartments and tissues. There are six types of physiological barriers: blood endothelial, cell membrane, blood-brain, blood-cerebrospinal fluid (CSF), blood-placenta, and blood-testis barriers.
The blood endothelial barrier is the most porous of these. It allows all small ionized, un-ionized, and lipophilic molecules to pass through the endothelial lining into the interstitial space...
The blood endothelial barrier is the most porous of these. It allows all small ionized, un-ionized, and lipophilic molecules to pass through the endothelial lining into the interstitial space...
5.3K
Hybridoma Technology
17.8K
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
17.8K


